Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary

Toumi has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global pharma major Lupin Limited has appointed Abdelaziz Toumi as chief executive officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS). LMS is engaged in the development, manufacture and sale of active pharmaceutical ingredients (APIs) and is starting to build its contract development and manufacturing operations (CDMO) business.

Toumi is a seasoned leader with a blend of scientific and commercial skills and brings over two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. He has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma, where he was responsible for driving growth, innovation and operational excellence. Toumi will be based in Switzerland and will spend considerable time in India.

Toumi holds a Doctorate in Chemical Engineering and a Master’s degree in Business Administration from the University of Southern Queensland.

Commenting on the appointment, Lupin’s managing director, Nilesh Gupta said, “We are delighted to welcome Abdel to our team. He brings a wealth of knowledge and experience in the API CDMO space and will be instrumental in establishing LMS as a trusted and preferred partner for our global customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics